(Q37096297)

18 August 2017

1 reference

title

Homing and engraftment of progenitor cells: a prerequisite for cell therapy (English)

1 reference

18 August 2017

3

Stefanie Dimmeler

0 references

Carmen Urbich

series ordinal

2

object named as

Carmen Urbich

1 reference

18 August 2017

Emmanouil Chavakis

1

1 reference

18 August 2017

language of work or name

1 reference

18 January 2008

1 reference

Journal of Molecular and Cellular Cardiology

18 August 2017

published in

1 reference

18 August 2017

volume

45

1 reference

18 August 2017

issue

4

1 reference

18 August 2017

page(s)

514-522

1 reference

Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Role of imaging in cardiac stem cell therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Cell-based therapies and imaging in cardiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Bone marrow stem cell imaging after intracoronary administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Intracoronary infusion of CD133+ and CD133-CD34+ selected autologous bone marrow progenitor cells in patients with chronic ischemic cardiomyopathy: cell isolation, adherence to the infarcted area, and body distribution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Monitoring of bone marrow cell homing into the infarcted human myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Adhesion mechanisms regulating the migration of monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Immune cell migration in inflammation: present and future therapeutic targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Getting to the site of inflammation: the leukocyte adhesion cascade updated

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Multistep nature of microvascular recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Myocardial homing and neovascularization by human bone marrow angioblasts is regulated by IL-8/Gro CXC chemokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Leukocyte-endothelial cell interactions in the inflammatory response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Interleukin-8 is associated with circulating CD133+ progenitor cells in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Bone Marrow Monocyte Lineage Cells Adhere on Injured Endothelium in a Monocyte Chemoattractant Protein-1–Dependent Manner and Accelerate Reendothelialization as Endothelial Progenitor Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Chemokines direct endothelial progenitors into tumor neovessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

High mobility group box 1 protein, a cue for stem cell recruitment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

High-Mobility Group Box 1 Activates Integrin-Dependent Homing of Endothelial Progenitor Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Involvement of E-selectin in recruitment of endothelial progenitor cells and angiogenesis in ischemic muscle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Endothelial E-selectin potentiates neovascularization via endothelial progenitor cell-dependent and -independent mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

PSGL-1-mediated activation of EphB4 increases the proangiogenic potential of endothelial progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Integrins: bidirectional, allosteric signaling machines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Essential role of ICAM-1/CD18 in mediating EPC recruitment, angiogenesis, and repair to the infarcted myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Functional disruption of alpha4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

LFA-1 and VLA-4 involved in human high proliferative potential-endothelial progenitor cells homing to ischemic tissue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

CD99 expressed on human mobilized peripheral blood CD34+ cells is involved in transendothelial migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Pericellular proteases in angiogenesis and vasculogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

In vivo trafficking of endothelial progenitor cells their possible involvement in the tumor neovascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Cathepsin L is required for endothelial progenitor cell-induced neovascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

High urokinase expression contributes to the angiogenic properties of endothelial cells derived from circulating progenitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Cell-enhancement strategies for the treatment of ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Estradiol enhances recovery after myocardial infarction by augmenting incorporation of bone marrow-derived endothelial progenitor cells into sites of ischemia-induced neovascularization via endothelial nitric oxide synthase-mediated activation of ma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Regulation of endothelial cell and endothelial progenitor cell survival and vasculogenesis by integrin-linked kinase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

p38 mitogen-activated protein kinase downregulates endothelial progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Expression of Vascular Endothelial Growth Factor, Stromal Cell-Derived Factor-1, and CXCR4 in Human Limb Muscle With Acute and Chronic Ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Exogenous High-Mobility Group Box 1 Protein Induces Myocardial Regeneration After Infarction via Enhanced Cardiac C-Kit+ Cell Proliferation and Differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Short-term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Mesenchymal stem cells use integrin beta1 not CXC chemokine receptor 4 for myocardial migration and engraftment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

Mechanism of human stem cell migration and repopulation of NOD/SCID and B2mnull NOD/SCID mice. The role of SDF-1/CXCR4 interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.01.004

10.1016/J.YJMCC.2008.01.004

7 January 2021

Identifiers

DOI

1 reference

18 August 2017

1 reference